Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
NCT06528418 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2025-03-26
Summary
The goal of this observational study is to develop an advanced expiratory algorithm model utilizing exhaled breath volatile organic compound (VOC) marker molecules. This model aims to accurately diagnose mutiple pulmonary diseases. The primary objectives it strives to accomplish are:
1. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose several common pulmonary diseases.
2. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose more pulmonary diseases.
Conditions
- Lung Cancer
- Lung Infection
- COPD
- Bronchitis
- Pulmonary Fibrosis
- Pulmonary Embolism
- Pulmonary Arterial Hypertension
- Pulmonary Tuberculosis
- Pulmonary Abscess
- Emphysema
- Lung Injury
- Cystic Fibrosis of the Lung
- Bronchial Asthma
- Bronchiectasis
- Interstitial Lung Disease
- Preserved Ratio Impaired Spirometry
Interventions
- OTHER
-
Gas chromatography-mass spectrometry(GC-MS) and micro Gas Chromatography-photoionisation detector (μGC-PID) system
Exhaled breath samples from these participants will be collected and analyzed to detect volatile organic compound molecules in human exhaled breath by GC-MS and μGC-PID
Sponsors & Collaborators
-
The First Affiliated Hospital of Guangzhou Medical University
collaborator OTHER -
First People's Hospital of Foshan
collaborator OTHER -
Sichuan Cancer Hospital and Research Institute
collaborator OTHER -
Liwan District Central Hospital
collaborator UNKNOWN -
Shanghai Chest Hospital
collaborator OTHER -
Peking Union Medical College Hospital
collaborator OTHER -
Guangzhou Development Zone Hospital
collaborator UNKNOWN -
Huangpu District Hongshan Street Community Health Service Center
collaborator UNKNOWN -
Huangpu District Chinese Medicine Hospital
collaborator UNKNOWN -
Fifth Affiliated Hospital of Guangzhou Medical University
collaborator OTHER -
Huangpu District Jiufo Street Community Health Service Center
collaborator UNKNOWN -
Huangpu District Xinlong Town Central Hospital
collaborator UNKNOWN -
Huangpu District Yonghe Street Community Health Service Center
collaborator UNKNOWN -
Huangpu District Lianhe Street Second Community Health Service Center
collaborator UNKNOWN -
ChromX Health
lead INDUSTRY
Principal Investigators
-
Jianxing He, MD · The First Affiliated Hospital of Guangzhou Medical University
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-06-30
- Primary Completion
- 2026-12-30
- Completion
- 2027-06-30
Countries
- China
Study Locations
More Related Trials
-
Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)
NCT00655694 ·Status: WITHDRAWN
-
The Individualized Accurate Diagnosis and Treatment of Chronic Objective Pulmonary Disease(COPD) Patients Based on Multidimensional Data
NCT04183530 ·Status: UNKNOWN
-
The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples
NCT01631162 ·Status: UNKNOWN ·Phase: NA
-
Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics
NCT05069194 ·Status: UNKNOWN
-
Identification of Volatile Organic Compounds in Exhaled Air During Exacerbation of Chronic Obstructive Pulmonary Disease
NCT02529891 ·Status: TERMINATED
-
The Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China
NCT03044847 ·Status: ENROLLING_BY_INVITATION
-
Metabolomic Analysis of Exhaled Breath Condensates in Patients With COPD and Bronchiectasis
NCT01410422 ·Status: UNKNOWN
-
The Severity Assessment Model for AECOPD With Combination of Disease and Syndrome
NCT06918353 ·Status: NOT_YET_RECRUITING
-
Novel Biomarkers in Chronic Airway Diseases
NCT00849836 ·Status: UNKNOWN
-
Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
NCT03170999 ·Status: COMPLETED
-
Prediction of Pulmonary Rehabilitation Outcomes in Patients With Chronic Respiratory Disease Based on Metabolomics: a Prospective Cohort Study
NCT05681364 ·Status: UNKNOWN
-
Respiratory Disease Cohort Studies of Chinese Medicine for COPD(RESEARCH-COPD)
NCT06577701 ·Status: NOT_YET_RECRUITING
-
Chinese Population Health and Multimorbidity Study
NCT07026370 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease
NCT02826265 ·Status: UNKNOWN
-
Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
NCT05727852 ·Status: ENROLLING_BY_INVITATION
-
Intestinal Microbiota in COPD and Asthma
NCT04802317 ·Status: COMPLETED
-
Pilot Study on Proteomics of Erythrocyte Proteins in Patients With COPD Based on TMT Technology
NCT05376618 ·Status: COMPLETED
-
Exploring Breathing Patterns
NCT04754490 ·Status: SUSPENDED
-
The Characteristic of Airway Microbiome Profiling of COPD-bronchiectasis Overlap Patients and Its Association With Acute Exacerbation
NCT04865861 ·Status: UNKNOWN
-
Multi-omics Studies of Host-microbiome Interaction in Chronic Obstructive Pulmonary Disease and Bronchiectasis
NCT05738044 ·Status: UNKNOWN
-
Quality Control for Chronic Obstructive Pulmonary Disease
NCT03604146 ·Status: COMPLETED
-
Air Pollution and Health of COPD Patients
NCT05076630 ·Status: COMPLETED
-
Biomarker of Acute Exacerbation of COPD
NCT04963244 ·Status: COMPLETED
-
A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population
NCT06724848 ·Status: RECRUITING
-
Optimization of Exhaled Biomarker Collection and Analysis
NCT05322785 ·Status: ENROLLING_BY_INVITATION ·Phase: NA